| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Battery Ventures XIV, L.P. | 22% | $6,482,461 | 11,575,824 | Battery Ventures XIV, L.P. | 23 Jun 2025 | |||
| Harbert Discovery Fund, LP | 9.9% | $2,898,511 | 5,175,913 | Harbert Fund Advisors, Inc. | 23 Jun 2025 |
As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of ENZO BIOCHEM INC - Common Stock (ENZB). This represents 0% of the company’s total 52,265,866 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$253,811 | $0.70 | 0 |
| 2025 Q2 | 374,753 | $253,811 | -$4,837,143 | $0.68 | 5 |
| 2025 Q1 | 13,413,698 | $4,960,065 | -$113,502 | $0.37 | 38 |
| 2024 Q4 | 13,597,198 | $9,711,626 | -$7,195 | $0.71 | 41 |
| 2024 Q3 | 12,649,378 | $14,167,341 | +$297,645 | $1.12 | 43 |
| 2024 Q2 | 12,379,977 | $13,491,693 | -$1,815,129 | $1.09 | 38 |
| 2024 Q1 | 13,822,512 | $17,554,428 | -$1,384,850 | $1.27 | 40 |
| 2023 Q4 | 16,353,828 | $22,730,158 | -$253,140 | $1.39 | 43 |
| 2023 Q3 | 16,535,325 | $23,147,958 | -$4,047,076 | $1.40 | 37 |
| 2023 Q2 | 18,837,559 | $34,660,589 | -$1,844,765 | $1.84 | 46 |
| 2023 Q1 | 19,784,854 | $48,075,146 | +$2,648,418 | $2.43 | 50 |
| 2022 Q4 | 18,768,816 | $26,837,531 | -$572,972 | $1.43 | 48 |
| 2022 Q3 | 20,460,994 | $45,627,000 | -$1,361,300 | $2.23 | 40 |
| 2022 Q2 | 20,838,745 | $43,134,000 | -$1,091,443 | $2.07 | 45 |
| 2022 Q1 | 21,381,707 | $62,014,000 | -$399,475 | $2.90 | 43 |
| 2021 Q4 | 21,493,197 | $68,996,860 | -$9,625,981 | $3.21 | 53 |
| 2021 Q3 | 23,434,734 | $82,938,591 | -$2,416,971 | $3.54 | 58 |
| 2021 Q2 | 24,165,446 | $76,602,267 | -$10,936,805 | $3.17 | 64 |
| 2021 Q1 | 27,495,711 | $94,572,268 | -$5,946,811 | $3.44 | 76 |
| 2020 Q4 | 29,312,323 | $73,874,557 | +$1,033,665 | $2.52 | 76 |
| 2020 Q3 | 28,944,341 | $61,065,881 | +$552,366 | $2.11 | 76 |
| 2020 Q2 | 28,587,129 | $64,041,502 | -$606,041 | $2.24 | 75 |
| 2020 Q1 | 28,850,783 | $72,990,987 | -$8,678,157 | $2.53 | 68 |
| 2019 Q4 | 32,226,819 | $84,756,164 | -$1,565,386 | $2.63 | 73 |
| 2019 Q3 | 32,635,685 | $117,485,930 | +$940,765 | $3.60 | 81 |
| 2019 Q2 | 32,484,483 | $109,472,796 | +$2,818,424 | $3.37 | 90 |
| 2019 Q1 | 32,152,748 | $87,769,028 | +$896,014 | $2.73 | 74 |
| 2018 Q4 | 31,775,434 | $88,334,227 | -$4,736,915 | $2.78 | 80 |
| 2018 Q3 | 31,526,845 | $129,879,010 | -$2,845,360 | $4.12 | 93 |
| 2018 Q2 | 31,922,848 | $165,663,708 | +$2,301,856 | $5.19 | 89 |
| 2018 Q1 | 31,456,069 | $172,370,738 | -$40,847 | $5.48 | 101 |
| 2017 Q4 | 30,933,821 | $252,147,674 | +$7,257,919 | $8.15 | 113 |
| 2017 Q3 | 29,882,486 | $312,881,860 | +$7,207,537 | $10.47 | 114 |
| 2017 Q2 | 29,185,874 | $322,214,819 | +$12,442,883 | $11.04 | 117 |
| 2017 Q1 | 28,303,218 | $236,881,486 | +$35,305,886 | $8.37 | 108 |
| 2016 Q4 | 27,072,818 | $187,873,845 | +$2,609,887 | $6.94 | 105 |
| 2016 Q3 | 23,763,534 | $120,948,418 | -$2,921,190 | $5.09 | 108 |
| 2016 Q2 | 24,268,026 | $144,878,758 | +$14,267,162 | $5.97 | 99 |
| 2016 Q1 | 22,131,772 | $100,550,000 | +$816,988 | $4.55 | 92 |
| 2015 Q4 | 21,913,377 | $98,615,619 | +$6,206,696 | $4.50 | 82 |
| 2015 Q3 | 21,113,551 | $66,932,568 | +$237,318 | $3.17 | 78 |
| 2015 Q2 | 21,076,977 | $63,858,030 | -$2,581,411 | $3.03 | 82 |
| 2015 Q1 | 22,099,043 | $65,215,225 | +$564,356 | $2.95 | 83 |
| 2014 Q4 | 21,324,235 | $94,677,617 | +$5,752,288 | $4.44 | 85 |
| 2014 Q3 | 19,660,641 | $101,245,804 | +$12,793,435 | $5.15 | 90 |
| 2014 Q2 | 17,217,448 | $90,322,177 | +$21,345,739 | $5.25 | 83 |
| 2014 Q1 | 13,299,282 | $55,310,893 | +$8,897,609 | $4.16 | 59 |